Clinical Trial: Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281781) titled 'Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow' on Dec. 04.

Brief Summary: This is a phase I/II protocol investigating whether Nelfinavir can improve anemia and lower serum fibrosis biomarkers in Myelofibrosis patients.

Study Start Date: Sept. 16

Study Type: INTERVENTIONAL

Condition: Myelofibrosis Myelofibrosis; Anemia

Intervention: DRUG: Nelfinavir

Taken twice daily

Recruitment Status: RECRUITING

Sponsor: University of California, Irvine

Information provided by (Responsible Party): Angela G. Fleischman, University of California, Irvine

Disclaimer: Curated...